CD8A and cancer: For instance, Belladonna et al. demonstrated that TGFβ1 promotes indoleamine 2,3-dioxygenase (IDO) expression and tolerogenic activity in both CD8− and CD8+ murine DC subsets [80], and IDO-producing regulatory DC play critical roles in anti-tumor immune suppression in various cancer types [81].